FAM66A Gene

Name family with sequence similarity 66, member A
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Recent genomic investigations have begun to uncover potential roles for FAM66A in human disease pathogenesis and clinical outcomes. In a study of copy number variants in African Americans with type 2 diabetes–associated end‐stage renal disease, a significant CNV insertion on chromosome 1—within which FAM66A is located—was identified. This finding raises the possibility that genomic alterations affecting FAM66A may contribute to disease susceptibility."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Moreover, improvements in epigenomic profiling techniques have emphasized the importance of accurately parsing genomic regions for true biological signals. In one study, careful attention to artifacts in DNA methylation measurements underscored the need to correctly identify modifications in regions that may include important genes such as FAM66A, thereby ensuring that epigenetic alterations are not misinterpreted."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Notably, expression analyses in small cell lung cancer have revealed that high levels of FAM66A, as part of a six‐gene prognostic signature, are associated with poorer overall survival. This suggests that FAM66A may serve as an important marker for aggressive disease and could potentially inform personalized treatment strategies in this cancer subtype."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In summary, although the precise biological function of FAM66A remains to be fully elucidated, current evidence indicates that it may play a multifaceted role in both metabolic and neoplastic disorders. Its involvement in genomic alterations and prognostic outcomes underscores the potential of FAM66A as a biomarker in precision medicine.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Jessica N Cooke Bailey, Lingyi Lu, Jeff W Chou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Role of Copy Number Variation in African Americans with Type 2 Diabetes-Associated End Stage Renal Disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Genet Med (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4172/1747-0862.1000061"}], "href": "https://doi.org/10.4172/1747-0862.1000061"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24707315"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24707315"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Wanding Zhou, Timothy J Triche, Peter W Laird, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SeSAMe: reducing artifactual detection of DNA methylation by Infinium BeadChips in genomic deletions."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nucleic Acids Res (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/nar/gky691"}], "href": "https://doi.org/10.1093/nar/gky691"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30085201"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30085201"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Shicheng Feng, Xiuxiu Zhang, Xuyu Gu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of Six Novel Prognostic Gene Signatures as Potential Biomarkers in Small Cell Lung Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Comb Chem High Throughput Screen (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2174/1386207325666220427121619"}], "href": "https://doi.org/10.2174/1386207325666220427121619"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35490316"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35490316"}]}]}]}
NCBI Gene ID 100133172
API
Download Associations
Predicted Functions View FAM66A's ARCHS4 Predicted Functions.
Co-expressed Genes View FAM66A's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View FAM66A's ARCHS4 Predicted Functions.

Functional Associations

FAM66A has 883 functional associations with biological entities spanning 3 categories (molecular profile, cell line, cell type or tissue, gene, protein or microRNA) extracted from 16 datasets.

Click the + buttons to view associations for FAM66A from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of FAM66A gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of FAM66A gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of FAM66A gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of FAM66A gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at FAM66A gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of FAM66A gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of FAM66A gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of FAM66A gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of FAM66A gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of FAM66A gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of FAM66A gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of FAM66A gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of FAM66A gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles cell types and tissues with high or low DNA methylation of FAM66A gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at FAM66A gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
TCGA Signatures of Differentially Expressed Genes for Tumors tissue samples with high or low expression of FAM66A gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.